Three out of 14 biomarkers: CD40, MCP-3, and PD-L2 had higher cervicovaginal levels in other EC than low-grade EEC group (P ranging from 0.008 to < 0.0001). This evidence concerns the gene PDCD1LG2 and exstrophy-epispadias complex.